Missed Chances on a Hopeful Road

Looking back, my scientific career seems to have been liberally strewn with missed opportunities. In fact, right at its outset I missed an opportunity by force of circumstance. After a six-year break in my studies occasioned by service with the Jewish Brigade in the 8th Army during World War II, I began work on my Ph.D. thesis at the Hebrew University in Jerusalem in 1947. The subject was a search for soil bacteria that would produce an antibiotic against typhoid and dysentery bacteria. At th

Written byAlexander Kohn
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Looking back, my scientific career seems to have been liberally strewn with missed opportunities. In fact, right at its outset I missed an opportunity by force of circumstance.

After a six-year break in my studies occasioned by service with the Jewish Brigade in the 8th Army during World War II, I began work on my Ph.D. thesis at the Hebrew University in Jerusalem in 1947. The subject was a search for soil bacteria that would produce an antibiotic against typhoid and dysentery bacteria. At that time the only two known antibiotics were penicillin and streptomycin. I got off to a rather successful start by isolating a Bacillus whose colonies had the peculiar property of rotating synchronously on agar plates. An extract of the broth in which these bacteria grew inhibited the growth of typhoid bacteria. This microorganism was indeed later found to produce polymyxin, but I had to give up ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies